GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$74.19
+0.86%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
14.5x
EV/EBITDA
10.8x
Market Cap
$9.96B
MomentumView details →
1D Return
+0.86%
YTD Return
−14.99%
RSI (14)
31.7
ValuationView details →
P/E (Fwd)
14.5x
EV/EBITDA
10.8x
Market Cap
$9.96B
RSI (14)
31.7
MomentumView details →
1D Return
+0.86%
YTD Return
−14.99%
SummaryUpdated Jun 1, 2026
Globus Medical, Inc. (NYSE:GMED) is a medical device company founded in 2003 and headquartered in Audubon, Pennsylvania. The company went public in 2012 and has grown through both organic expansion and strategic acquisitions to become a major player in the musculoskeletal medical device market. In September 2023, Globus completed a transformative merger with NuVasive, significantly expanding its product portfolio and global reach. The company has evolved from a spine-focused specialist into a comprehensive musculoskeletal solutions provider, offering products for spine, trauma, orthopedics, and enabling technologies including robotic surgical systems.
Similar companies
Latest newsMore news →
Globus Medical announced CE Mark approval for its Excelsius3D imaging system, expanding its Excelsius ecosystem in the European Union.8d agoGlobus Medical, Inc. announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University, to transform healthcare experience through AI-driven digital solutions.16d ago